Jamel Benkreira, General Manager – United Kingdom & Ireland at Aspargo Labs, is a senior pharmaceutical executive with over 22 years of experience leading commercial teams and launching products across global markets outside the U.S.

Before joining Aspargo, Mr. Benkreira held several key positions at Pharming, including Head of EMEA, where he led the business strategy for the upcoming launch of a rare disease product in the region. His career includes roles at Bristol-Myers Squibb, GlaxoSmithKline, ViiV Healthcare, Pfizer, and Aimmune Therapeutics.

He has managed products through their full lifecycle, from pre-clinical development to commercialization, market expansion, and loss of exclusivity. His expertise spans multiple therapeutic areas, including cardiovascular disease, mental health, oncology, respiratory conditions, HIV, peanut allergy and rare diseases.

Mr. Benkreira holds a BSc in Biochemistry & Genetics from the University of Leeds, United Kingdom.